Oncogenomics

This transformation is determined by both inherited genetic factors and somatic genetic alterations and mutations, and it results in uncontrolled cell growth and leads to death. The genetic mutations that lead to cancer occur only in certain genes. Cancer-causing genes have been classified as proto-oncogenes (e.g., the genes for MYC, ERBB2 and EGFR) and tumor suppressor genes such as the genes that encode TP53, CDKN2A, and RB.

The completion of the Human Genome Project simplified the field of oncogenomic and improved the abilities of researchers to find oncogenes. Sequencing technologies and global methylation profiling methods are practiced to the study of oncogenomics.

 

  • mammaglobin gene
  • lipophilin B
  • human chromosome 17

Related Conference of Oncogenomics

December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Paris, France
February 05-06, 2026

11th World Conference on Breast and Cervical Cancer

Paris, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 09-10, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
September 29-30, 2026

5th Experts Meeting on Cancer Medicine, Radiology & Treatment

Aix-en-Provence, France

Oncogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in